Cross-border life-sciences collaborations—whether for drug discovery, medical devices, diagnostics or digital health platforms—are typically built on sophisticated IP-licensing structures. Yet when ...
Over the past decade, the landscape of cross-border partnering in the life sciences sector has undergone a dramatic transformation, particularly in transactions between Chinese biotech companies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results